Abiopharma

Enliven Therapeutics Reports Inducement Grants as Permitted by the Nasdaq Listing Rules

UTHR: Notification

UTHR: Notification

Zoetis - Zoetis Declares First Quarter 2026 Dividend; Board Approves 6% Payment Increase

Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry

Zoetis Declares First Quarter 2026 Dividend; Board Approves 6% Payment Increase

Crinetics Announces First Patient Dosed in Pivotal Adult Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH)

Dyne Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares

Terns Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Tenaya Therapeutics Announces Proposed Public Offering